A detailed history of Draper Asset Management, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Draper Asset Management, LLC holds 5,586 shares of VRTX stock, worth $2.62 Million. This represents 1.95% of its overall portfolio holdings.

Number of Shares
5,586
Previous 5,576 0.18%
Holding current value
$2.62 Million
Previous $2.27 Million 2.95%
% of portfolio
1.95%
Previous 1.97%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

BUY
$407.69 - $446.08 $4,076 - $4,460
10 Added 0.18%
5,586 $2.34 Million
Q4 2023

Feb 12, 2024

BUY
$343.0 - $410.68 $4,459 - $5,338
13 Added 0.23%
5,576 $2.27 Million
Q3 2023

Nov 02, 2023

BUY
$338.18 - $362.46 $222,184 - $238,136
657 Added 13.39%
5,563 $1.93 Million
Q2 2023

Aug 02, 2023

BUY
$314.42 - $351.91 $1.54 Million - $1.73 Million
4,906 New
4,906 $1.73 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $120B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Draper Asset Management, LLC Portfolio

Follow Draper Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Draper Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Draper Asset Management, LLC with notifications on news.